Meeting News

Spain’s Dr. Pilar Garrido reviews long-term efficacy, safety, and predictors-of-response data for post-platinum advanced NSCLC patients with EGFR exon 20 insertion mutations.

Dr. Christine Berg says both smoking and air pollution are important in causing lung cancer. And both need to be eliminated to help prevent it and save lives.

A team of NCI researchers recently investigated what needs to happen for the United States to reach President Biden’s goal of cutting cancer mortality by 50% by 2047.

During IASLC’s 2023 Hot Topic Meeting on small cell lung cancer, Dr. Trudy Oliver discussed how MYC genes drive the evolution of SCLC subtypes.

From new diagnostic approaches to new evidence on the potential mechanisms of treatment resistance, Dr. Charles M. Rudin looked back on how small cell research has evolved and what needs remain.

The Netherlands Cancer Institute’s Dr. Paul Baas was honored for his significant contributions to lung cancer research during the 2023 European Lung Cancer Congress.

Consensus eluded 2023 European Lung Cancer Congress attendees during a debate on the best approach for NSCLC.

Stephen Liu, MD, and Tina Cascone, MD, PhD, share what attendees can expect at the first ever Texas Lung Cancer Conference, an upcoming two-day CME meeting endorsed by the IASLC.

In addressing fellow TTLC 23 faculty, Dr. Langer recounted the perils and pitfalls, promises and poetry he has experienced in his 35 years in the field.